Manufacturing and Analytical Characterization - Biomolecular

(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique

(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor

(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing

(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies

(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates

(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets

(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive

(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy

(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles

(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing

(W1130-11-61) Forced Degradation of Cell-Based Therapeutic Products Using Various Stresses and Use of Flow Imaging Microscopy for Identification of Damaged Cells and Cell Debris

(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber

(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture

(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug

(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions

(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles

(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities

(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases

(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking

(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)

(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies

(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay

(M1430-11-60) Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry

(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products

(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments

(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application